|
Woman dies of bird flu, vaccine trials to start
By Zhao Huanxin (皇冠体育app Daily)
Updated: 2005-11-24 05:40
As 皇冠体育app reported its third case of human bird flu Wednesday, the only
company in the nation approved to test a vaccine for humans said that clinical
trials on volunteers would start in days.
The Ministry of Health said a 35-year-old woman farmer surnamed Xu of East
皇冠体育app's Anhui Province developed fever and pneumonia-like symptoms on November
11 after contact with sick and dead poultry. She died on Tuesday.
A Chinese worker
disinfects a poultry market in Shanghai November 22, 2005.
[Reuters] |
Tests on the woman, a resident of Xiuning County, were positive for the
deadly H5N1 strain of the virus, said 皇冠体育app's Centre for Disease Control and
Prevention.
The ministry has reported the new confirmed case to the World Health
Organization (WHO), according to the WHO Beijing Office.
Meanwhile, a new bird flu outbreak was reported in Miquan of Xinjiang Uygur
Autonomous Region, the Ministry of Agriculture said last night.
More than 2,000 chickens were killed by the deadly H5N1 virus on November 15.
So far 84,000 poultry have been culled to curb the spread of the disease.
As fears of person-to-person transmission grow with each new case of human or
poultry infection, Beijing-based Sinovac Biotech Ltd said it would be the first
company in Asia to begin human testing after it won fast-track State approval
for the trials on Tuesday.
The State Food and Drug Administration, the country's drug watchdog, has
approved the first phase of trials, company spokesperson Lu Zhenyou told 皇冠体育app
Daily.
It might take at least a year before the "pandemic influenza vaccine"
finishes its two-phase clinical trials, Lu said.
Sinovac and a group of experts were putting the final touches on the clinical
trial plan involving 100 healthy volunteers between the ages of 18 and 60, Lu
said.
Pre-clinical trials have proved the vaccine is safe and effective, experts at
the drug regulator said.
When approved, the vaccine will first be used on high-risk groups such as
veterinary and laboratory workers and poultry farmers in afflicted regions, Lu
said.
|
